Follow us

Nanomedicine
For Precision
Radio-Oncology

Nanomedicine
For Precision
Radio-Oncology

Nanomedicine
For Precision
Radio-Oncology

Nanomedicine
For Precision
Radio-Oncology

Nanomedicine
For Precision
Radio-Oncology

Nanomedicine
For Precision
Radio-Oncology

AGuIX®: an innovative nanodrug with the aim to improve radiotherapy treatment of cancer

Nanomedicine technology
leduc-geraldine-nhtheraguix

« NH TherAguix has developed an innovative nano drug to improve cancer treatment by radiotherapy. Its pharmacological properties and its mode of action by bio-distribution allow it to act in the heart of tumors and confer it a pan-cancer potential.
This is a tremendous hope for many patients whose medical needs are currently unmet. »

Vincent Carrère, CEO of NH TherAguix

Some figures about NH TherAguix

YEARS OF CLINICAL RESEARCH

SCIENTIFIC PAPERS

PATENT FAMILIES

ON-GOING CLINICAL TRIALS

%

OF CANCER PATIENTS ARE TREATED BY RADIOTHERAPY

%

MORE PATIENTS TO BE TREATED WITH RADIOTHERAPY BY 2025

EVENTS

PRESS RELEASE

SCIENTIFIC PUBLICATIONS